At MedNet Solutions, we are dedicated to providing the highest quality training and supportive services possible to help our customers succeed and to ensure they get the most out of thier technology.
Sherpa’s packaging, storage, and distribution services are built with the customer in mind. As the Sherpas of the clinical packaging world, our team is empowered to guide you to the best strategic clinical supply solution for your project while ensuring your deadlines are met.
Electronic Informed Consent (eConsent) is the next big technological innovation in clinical trials. 146 respondents from 100 biotech, pharmaceutical, CRO, and IRB organizations shared their experiences, expectations, and ideas about the future of eConsent. Whether you’re just starting to consider eConsent or ready to expand adoption, download this report for insight on what is likely to be the next “must-have” in clinical trials.
PCI is an integrated full service provider and a trusted partner to leading companies in the global healthcare industry; we offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to commercial launch, delivering speed to market and commercial success for our customers. Core services include: Analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, QP services, supply chain management, storage and distribution.
We design the best program for your product and patient population by using the right combination of
high-touch services and high-tech solutions.
In patient support programs, success—and your ROI—rests on making that vital connection between technology and the human touch.
While developing drugs to treat rare diseases is more viable from a business perspective than ever before, the clinical research and go-to-market planning process is still fraught with challenges. Regulations, protocols, logistics, and reporting are all different when patients are scarce, the stakes are high, and treatments are complex.
While developing drugs to treat rare diseases is more viable from a business perspective than ever before, the clinical research and go-to-market planning process is still fraught with challenges. Regulations, protocols, logistics, and reporting are all different when patients are scarce, the stakes are high, and treatments are complex.
Time and again, when we ask our partners in clinical development roles what their number one concern is, they respond that recruiting clinical trial patients and sites on-time and on-budget is an enormous and expensive challenge.
|
|
|
|
|
|
|
|
|